3 ms·
The "full price" here was 15 percent of GlaxoSmithKline's revenue last year. They spent 40 percent on marketing. When can this myth die? http://www.bizjournals
by cmdrfred 10y ago
The "full price" here was 15 percent of GlaxoSmithKline's revenue last year. They spent 40 percent on marketing. When can this myth die?
http://www.bizjournals.com/triangle/news/2016/07/19/where-gsk-ranks-in-r-d-spending-against-sales-and.html http://www.bizjournals.com/triangle/news/2016/07/19/where-gs...
- vonmoltke 10y agoProbably about the same time as people stop equating "general and administration expenses" with "marketing". Marketing is a subset of that.
- cmdrfred 10y agoYes, it also includes buying lunches for doctors and private jets for the executive staff. What it does not include is R&D in any shape or form. The fact is R&D isn't making drug prices high.
- vonmoltke 10y agoOy. It also includes paying the janitors, the property taxes, and the myriad of other costs that come with running a company. > The fact is R&D isn't making drug prices high. Neither are their SGA expenses. The two combined are just under half GSK's revenue. Anyway, that's irrelevant to trying to score cheap points with a false equivalence.